Zomedica Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	7.5	7.02	12.95	27.4	194.95	61.99
Short-Term Investments	45.63	64.33	77.55	87.69	-	-
Cash & Short-Term Investments	53.12	71.35	90.5	115.09	194.95	61.99
Cash Growth	-30.90%	-21.15%	-21.37%	-40.96%	214.48%	3915.48%
Accounts Receivable	3.14	2.42	1.2	0.6	0.32	-
Other Receivables	0.49	0.65	1	1.27	0.45	0.15
Receivables	3.63	3.07	2.2	1.86	0.77	0.15
Inventory	5.52	5.06	5.12	2.75	2.85	-
Prepaid Expenses	2.42	2.29	2.06	3.8	1.84	1.73
Total Current Assets	64.69	81.77	99.88	123.5	200.41	63.87
Property, Plant & Equipment	23.56	26.2	25.29	9.17	2.87	1.9
Long-Term Investments	1.24	-	10.01	40.71	-	-
Goodwill	-	45.56	61.58	63.98	43.29	-
Other Intangible Assets	40.1	52.54	55.36	41.8	33.18	0.36
Other Long-Term Assets	1.31	1.29	1.07	0.45	0.66	0.01
Total Assets	130.91	207.36	253.2	279.61	280.4	66.14
Accounts Payable	1.65	1.93	2.07	6.7	3.23	1.25
Accrued Expenses	5.43	6.1	5.35	-	-	-
Short-Term Debt	-	-	-	-	-	0.53
Current Portion of Leases	0.71	0.52	0.92	0.64	0.42	0.25
Current Income Taxes Payable	0.05	0.12	0.07	0.19	0.24	-
Current Unearned Revenue	0.35	0.33	0.28	0.21	0.2	-
Other Current Liabilities	0.25	0.34	0.36	0.08	0.26	-
Total Current Liabilities	8.43	9.33	9.03	7.81	4.34	2.03
Long-Term Leases	1.65	1.29	1.81	1.1	0.96	1.09
Long-Term Unearned Revenue	0.24	0.22	0.25	0.18	0.14	-
Long-Term Deferred Tax Liabilities	0.44	0.46	1.14	1.25	3.71	-
Other Long-Term Liabilities	0.47	0.4	0.94	1.88	0.36	-
Total Liabilities	11.22	11.7	13.18	12.22	9.51	3.12
Common Stock	380.97	380.97	380.97	380.97	380.96	104.78
Additional Paid-In Capital	33.77	32.52	29.93	23.67	9.31	14.79
Retained Earnings	-295.24	-217.92	-170.93	-136.4	-119.39	-68.97
Comprehensive Income & Other	0.19	0.09	0.05	-0.84	0	0.46
Total Common Equity	119.69	195.66	240.02	267.39	270.89	51.07
Shareholders' Equity	119.69	195.66	240.02	267.39	270.89	63.03
Total Liabilities & Equity	130.91	207.36	253.2	279.61	280.4	66.14
Total Debt	2.35	1.81	2.73	1.74	1.38	1.87
Net Cash (Debt)	50.77	69.54	87.77	113.35	193.57	60.12
Net Cash Growth	-32.12%	-20.77%	-22.57%	-41.44%	221.96%	3794.47%
Net Cash Per Share	0.05	0.07	0.09	0.12	0.20	0.16
Filing Date Shares Outstanding	979.95	979.95	979.95	979.95	979.9	947.3
Total Common Shares Outstanding	979.95	979.95	979.95	979.95	979.9	642.04
Working Capital	56.26	72.44	90.85	115.69	196.07	61.84
Book Value Per Share	0.12	0.20	0.24	0.27	0.28	0.08
Tangible Book Value	79.59	97.57	123.07	161.61	194.42	50.7
Tangible Book Value Per Share	0.08	0.10	0.13	0.16	0.20	0.08
Machinery	16.58	17.03	10.44	6.85	1.73	0.72
Construction In Progress	6.58	7.89	12.48	0.69	0.42	-
Leasehold Improvements	2.82	3.09	1.95	1.24	0.29	0.57

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.